BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2557797)

  • 1. Gm haplotypes in inflammatory demyelinating polyneuropathies.
    Feeney DJ; Pollard JD; McLeod JG; Stewart GJ; De Lange GG
    Ann Neurol; 1989 Dec; 26(6):790-2. PubMed ID: 2557797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization and risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Choudhary PP; Osborn M; Rees JH; Sanders EA
    Muscle Nerve; 1996 Sep; 19(9):1230-1. PubMed ID: 8761286
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
    Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV
    Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-GD1a ganglioside antibodies in peripheral motor syndromes.
    Carpo M; Nobile-Orazio E; Meucci N; Gamba M; Barbieri S; Allaria S; Scarlato G
    Ann Neurol; 1996 Apr; 39(4):539-43. PubMed ID: 8619533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: pathogenesis and treatment.
    Koski CL
    Semin Neurol; 1994 Jun; 14(2):123-30. PubMed ID: 7984827
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated serum levels of endothelial leukocyte adhesion molecules in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Oka N; Akiguchi I; Kawasaki T; Ohnishi K; Kimura J
    Ann Neurol; 1994 May; 35(5):621-4. PubMed ID: 7513983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammatory and immunologically-induced diseases of the peripheral nerves].
    Wiethölter H; Dichgans J
    Internist (Berl); 1984 Oct; 25(10):599-606. PubMed ID: 6094383
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
    Irie S; Saito T; Kanazawa N; Ito H; Kowa H
    Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peripheral neuropathies].
    Mellgren SI
    Tidsskr Nor Laegeforen; 1995 May; 115(14):1735-8. PubMed ID: 7785034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Barohn RJ; Saperstein DS
    Semin Neurol; 1998; 18(1):49-61. PubMed ID: 9562667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammatory demyelinating diseases if the peripheral nervous system: immunological concepts and experimental models].
    Vass K; Lassmann H
    Wien Klin Wochenschr Suppl; 1991; 190():13-6. PubMed ID: 1771901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiganglioside antibodies in peripheral neuropathies].
    Pardo J
    Neurologia; 2001; 16(7):289-92. PubMed ID: 11485720
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of certain immune deficient peripheral neuropathies with intravenous immunoglobulins].
    Pouget J
    Rev Prat; 1994 Nov; 44(18):2404-6. PubMed ID: 7855497
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA antigens in the Landry-Guillain-Barré syndrome and chronic relapsing polyneuritis.
    Stewart GJ; Pollard JD; McLeod JG; Wolnizer CM
    Ann Neurol; 1978 Sep; 4(3):285-9. PubMed ID: 718142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic immune demyelinating neuropathies.
    Lopate G; Pestronk A
    Semin Neurol; 1994 Jun; 14(2):131-6. PubMed ID: 7527153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies.
    Cornblath DR; Griffin JW; Tennekoon GI
    Ann Neurol; 1986 Sep; 20(3):370-2. PubMed ID: 2429614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy.
    Vedeler CA; Matre R; Nyland H
    Acta Neurol Scand; 1988 Nov; 78(5):401-7. PubMed ID: 2464267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue in immune-mediated neuropathies.
    Merkies IS; Faber CG
    Neuromuscul Disord; 2012 Dec; 22 Suppl 3():S203-7. PubMed ID: 23182640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.